Hospitals in Britain begin 'gamechanger' approach to heart failure

People in Britain with heart failure are being given larger doses of drugs at the start of their treatment after a global study found that led to a huge fall in deaths.

- Denis Campbell

Experts say the new approach could mean those with the potentially fatal condition start receiving their ideal amount of medication within two weeks of diagnosis rather than many months.

Evidence from other countries found that it cut deaths from heart failure by 62% and lowered the risk of ending up back in hospital by 30%.

Those were among the key findings of the Strong-HF trial involving 87 hospitals in 14 countries.